Related Experiment Video
Updated: Aug 21, 2026

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations
Published on: July 24, 2021
[Multidrug resistance and new anti-infective agents]
Katja Schneider1, Stefan Hagel1, Maria J G T Vehreschild2
1Institut für Infektionsmedizin und Krankenhaushygiene, Universitätsklinikum Jena, Friedrich-Schiller-Universität Jena, Am Klinikum 1, 07747, Jena, Deutschland.
None:
Multidrug-resistant pathogens are among the greatest global health threats. Among Gram-negative pathogens, the worldwide rise in carbapenem resistance is of particular clinical significance; among Gram-positive pathogens, methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci are of primary concern. Resistance mechanisms include changes in penicillin-binding proteins, enzymatic inactivation by β‑lactamases, porin modifications, and efflux pumps. Targeted therapy for infections caused by multidrug-resistant pathogens requires knowledge of the resistance mechanism and a phenotypic antibiotic susceptibility profile. New β‑lactam/β-lactamase inhibitor combinations have largely replaced older therapeutic approaches such as colistin for infections caused by multidrug-resistant Gram-negative pathogens due to their superior efficacy and tolerability. The recently published first German S3 guideline, "Antibiotic Therapy for Severe Infections Caused by Multidrug-Resistant Bacteria," provides practice-oriented treatment recommendations for infections caused by multidrug-resistant pathogens.
More Related Videos
Related Concept Videos
Development of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Antibody Actions
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Antibiotic Selection
Clinical Significance of Antibiotic Resistance
Combined Effects of Drugs: Synergism
Such synergistic combinations...

